Approvals/UK EMC/Nuvaxovid JN.1 PFS dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

Approved

STANDARD

Nuvaxovid JN.1 PFS dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

Novavax, Inc🇬🇧 Electronic Medicines Compendium

Approval Id: 0d6cf26f71502695
Drug Approval Emc Name: Nuvaxovid JN.1 PFS dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)
Drug Name: Nuvaxovid JN.1 PFS dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)
Company Name: Novavax, Inc
Company Address: 21 Firstfield Road, Gaithersburg, Maryland, 20878, USA
Company Website: //www.Novavax.com
Company Telephone: +1 240-268-2000
Company Medical Info Direct Line: +44 020 3514 1838
Company Customer Care Direct Line: +44 020 3514 1838
Atc Code: J07BN04
Legal Category: Prescription only medicine

Approved

Agency

UK EMC

Country

🇬🇧

Approval ID

0d6cf26f71502695

Type

Standard